Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2007, Article ID 12781, 12 pages
http://dx.doi.org/10.1155/2007/12781
Review Article

Genetic Manipulations of PPARs: Effects on Obesity and Metabolic Disease

The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA

Received 7 August 2006; Revised 10 November 2006; Accepted 16 November 2006

Academic Editor: Wallace Harrington

Copyright © 2007 Yaacov Barak and Suyeon Kim. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Issemann and S. Green, “Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators,” Nature, vol. 347, no. 6294, pp. 645–650, 1990. View at Publisher · View at Google Scholar
  2. O. Braissant, F. Foufelle, C. Scotto, M. Dauça, and W. Wahli, “Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat,” Endocrinology, vol. 137, no. 1, pp. 354–366, 1996. View at Publisher · View at Google Scholar
  3. S. S.-T. Lee, T. Pineau, J. Drago et al., “Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators,” Molecular and Cellular Biology, vol. 15, no. 6, pp. 3012–3022, 1995. View at Google Scholar
  4. T. Aoyama, J. M. Peters, N. Iritani et al., “Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor a (PPARa),” Journal of Biological Chemistry, vol. 273, no. 10, pp. 5678–5684, 1998. View at Publisher · View at Google Scholar
  5. J. M. Peters, N. Hennuyer, B. Staels et al., “Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor a-deficient mice,” Journal of Biological Chemistry, vol. 272, no. 43, pp. 27307–27312, 1997. View at Publisher · View at Google Scholar
  6. P. Costet, C. Legendre, J. Moré, A. Edgar, P. Galtier, and T. Pineau, “Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis,” Journal of Biological Chemistry, vol. 273, no. 45, pp. 29577–29585, 1998. View at Publisher · View at Google Scholar
  7. M. E. Poynter and R. A. Daynes, “Peroxisome proliferator-activated receptor α activation modulates cellular redox status, represses nuclear factor-κB signaling, and reduces inflammatory cytokine production in aging,” Journal of Biological Chemistry, vol. 273, no. 49, pp. 32833–32841, 1998. View at Publisher · View at Google Scholar
  8. T. E. Akiyama, C. J. Nicol, C. Fievet et al., “Peroxisome proliferator-activated receptor-a regulates lipid homeostasis, but is not associated with obesity. Studies with congenic mouse lines,” Journal of Biological Chemistry, vol. 276, no. 42, pp. 39088–39093, 2001. View at Publisher · View at Google Scholar
  9. Y. Lee, X. Yu, F. Gonzales et al., “PPARa is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 18, pp. 11848–11853, 2002. View at Publisher · View at Google Scholar
  10. T. C. Leone, C. J. Weinheimer, and D. P. Kelly, “A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: the PPARα-null mouse as a model of fatty acid oxidation disorders,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 13, pp. 7473–7478, 1999. View at Publisher · View at Google Scholar
  11. S. Kersten, J. Seydoux, J. M. Peters, F. J. Gonzalez, B. Desvergne, and W. Wahli, “Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting,” Journal of Clinical Investigation, vol. 103, no. 11, pp. 1489–1498, 1999. View at Google Scholar
  12. M. C. Sugden, K. Bulmer, G. F. Gibbons, B. L. Knight, and M. J. Holness, “Peroxisome-proliferator-activated receptor-α (PPARα) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin,” Biochemical Journal, vol. 364, no. 2, pp. 361–368, 2002. View at Publisher · View at Google Scholar
  13. S. S.-T. Lee, W.-Y. Chan, C. K. C. Lo, D. C. C. Wan, D. S. C. Tsang, and W.-T. Cheung, “Requirement of PPARα in maintaining phospholipid and triacylglycerol homeostasis during energy deprivation,” Journal of Lipid Research, vol. 45, no. 11, pp. 2025–2037, 2004. View at Publisher · View at Google Scholar
  14. J. Xu, G. Xiao, C. Tirujillo et al., “Peroxisome proliferator-activated receptor a (PPARa) influences substrate utilization for hepatic glucose production,” Journal of Biological Chemistry, vol. 277, no. 52, pp. 50237–50244, 2002. View at Publisher · View at Google Scholar
  15. R. H. J. Bandsma, T. H. van Dijk, A. ter Harmsel et al., “Hepatic de novo synthesis of glucose-6-phosphate is not affected in PPARa-deficient mice but is preferentially directed towards hepatic glycogen stores after a short-term fast,” Journal of Biological Chemistry, vol. 279, no. 10, pp. 8930–8937, 2004. View at Publisher · View at Google Scholar
  16. J. M. Huss and D. P. Kelly, “Nuclear receptor signaling and cardiac energetics,” Circulation Research, vol. 95, no. 6, pp. 568–578, 2004. View at Publisher · View at Google Scholar
  17. K. Watanabe, H. Fujii, T. Takahashi et al., “Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor a associated with age-dependent cardiac toxicity,” Journal of Biological Chemistry, vol. 275, no. 29, pp. 22293–22299, 2000. View at Publisher · View at Google Scholar
  18. F. Djouadi, C. J. Weinheimer, J. E. Saffitz et al., “A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor a-deficient mice,” Journal of Clinical Investigation, vol. 102, no. 6, pp. 1083–1091, 1998. View at Google Scholar
  19. B. N. Finck, J. J. Lehman, T. C. Leone et al., “The cardiac phenotype induced by PPARa overexpression mimics that caused by diabetes mellitus,” Journal of Clinical Investigation, vol. 109, no. 1, pp. 121–130, 2002. View at Publisher · View at Google Scholar
  20. M. Guerre-Millo, C. Rouault, P. Poulain et al., “PPAR-a-null mice are protected from high-fat diet-induced insulin resistance,” Diabetes, vol. 50, no. 12, pp. 2809–2814, 2001. View at Publisher · View at Google Scholar
  21. C. Bernal-Mizrachi, S. Weng, C. Feng et al., “Dexamethasone induction of hypertension and diabetes is PPAR-a dependent in LDL receptor-null mice,” Nature Medicine, vol. 9, no. 8, pp. 1069–1075, 2003. View at Publisher · View at Google Scholar
  22. D. Patsouris, J. K. Reddy, M. Müller, and S. Kersten, “Peroxisome proliferator-activated receptor α mediates the effects of high-fat diet on hepatic gene expression,” Endocrinology, vol. 147, no. 3, pp. 1508–1516, 2006. View at Publisher · View at Google Scholar
  23. M. Haluzik, O. Gavrilova, and D. LeRoith, “Peroxisome proliferator-activated receptor-α deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic-euglycemic clamp studies,” Endocrinology, vol. 145, no. 4, pp. 1662–1667, 2004. View at Publisher · View at Google Scholar
  24. K. K. Islam, B. L. Knight, K. N. Frayn, D. D. Patel, and G. F. Gibbons, “Deficiency of PPARα disturbs the response of lipogenic flux and of lipogenic and cholesterogenic gene expression to dietary cholesterol in mouse white adipose tissue,” Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, vol. 1734, no. 3, pp. 259–268, 2005. View at Publisher · View at Google Scholar
  25. D. M. Muoio, P. S. MacLean, D. B. Lang et al., “Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) a knock-out mice. Evidence for compensatory regulation by PPARd,” Journal of Biological Chemistry, vol. 277, no. 29, pp. 26089–26097, 2002. View at Publisher · View at Google Scholar
  26. B. N. Finck, C. Bernal-Mizrachi, D. H. Han et al., “A potential link between muscle peroxisome proliferator-activated receptor-a signaling and obesity-related diabetes,” Cell Metabolism, vol. 1, no. 2, pp. 133–144, 2005. View at Publisher · View at Google Scholar
  27. C. Knauf, J. Rieusset, M. Foretz et al., “Peroxisome proliferator-activated receptor-a-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: role in liver and brain,” Endocrinology, vol. 147, no. 9, pp. 4067–4078, 2006. View at Publisher · View at Google Scholar
  28. J. M. Lehmann, L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer, “An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ),” Journal of Biological Chemistry, vol. 270, no. 22, pp. 12953–12956, 1995. View at Publisher · View at Google Scholar
  29. B. M. Forman, P. Tontonoz, J. Chen, R. P. Brun, B. M. Spiegelman, and R. M. Evans, “15-Deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ,” Cell, vol. 83, no. 5, pp. 803–812, 1995. View at Publisher · View at Google Scholar
  30. P. Tontonoz, E. Hu, and B. M. Spiegelman, “Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor,” Cell, vol. 79, no. 7, pp. 1147–1156, 1994. View at Publisher · View at Google Scholar
  31. E. D. Rosen, P. Sarraf, A. E. Troy et al., “PPAR? is required for the differentiation of adipose tissue in vivo and in vitro,” Molecular Cell, vol. 4, no. 4, pp. 611–617, 1999. View at Publisher · View at Google Scholar
  32. W. He, Y. Barak, A. Hevener et al., “Adipose-specific peroxisome proliferator-activated receptor ? knockout causes insulin resistance in fat and liver but not in muscle,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 26, pp. 15712–15717, 2003. View at Publisher · View at Google Scholar
  33. T. Imai, R. Takakuwa, S. Marchand et al., “Peroxisome proliferator-activated receptor ? is required in mature white and brown adipocytes for their survival in the mouse,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 13, pp. 4543–4547, 2004. View at Publisher · View at Google Scholar
  34. Y. Barak, M. C. Nelson, E. S. Ong et al., “PPAR? is required for placental, cardiac, and adipose tissue development,” Molecular Cell, vol. 4, no. 4, pp. 585–595, 1999. View at Publisher · View at Google Scholar
  35. J. M. Olefsky and A. R. Saltiel, “PPARγ and the treatment of insulin resistance,” Trends in Endocrinology and Metabolism, vol. 11, no. 9, pp. 362–368, 2000. View at Publisher · View at Google Scholar
  36. J. Plutzky, “The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis,” The American Journal of Cardiology, vol. 92, no. 4, supplement 1, pp. 34–41, 2003. View at Publisher · View at Google Scholar
  37. M. D. Tallquist and P. Soriano, “Epiblast-restricted Cre expression in MORE mice: a tool to distinguish embryonic vs. extra-embryonic gene function,” Genesis, vol. 26, no. 2, pp. 113–115, 2000. View at Publisher · View at Google Scholar
  38. S. Hayashi, P. Lewis, L. Pevny, and A. P. McMahon, “Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain,” Mechanisms of Development, vol. 119, 1, pp. S97–S101, 2002. View at Publisher · View at Google Scholar
  39. N. Kubota, Y. Terauchi, H. Miki et al., “PPAR? mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance,” Molecular Cell, vol. 4, no. 4, pp. 597–609, 1999. View at Publisher · View at Google Scholar
  40. P. D. G. Miles, Y. Barak, W. He, R. M. Evans, and J. M. Olefsky, “Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency,” Journal of Clinical Investigation, vol. 105, no. 3, pp. 287–292, 2000. View at Google Scholar
  41. P. D. G. Miles, Y. Barak, R. M. Evans, and J. M. Olefsky, “Effect of heterozygous PPARγ deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding,” American Journal of Physiology - Endocrinology and Metabolism, vol. 284, no. 3, pp. E618–E626, 2003. View at Google Scholar
  42. T. Yamauchi, H. Waki, J. Kamon et al., “Inhibition of RXR and PPAR? ameliorates diet-induced obesity and type 2 diabetes,” Journal of Clinical Investigation, vol. 108, no. 7, pp. 1001–1013, 2001. View at Publisher · View at Google Scholar
  43. T. Yamauchi, J. Kamon, H. Waki et al., “The mechanisms by which both heterozygous peroxisome proliferator-activated receptor ? (PPAR?) deficiency and PPAR? agonist improve insulin resistance,” Journal of Biological Chemistry, vol. 276, no. 44, pp. 41245–41254, 2001. View at Publisher · View at Google Scholar
  44. T. E. Akiyama, S. Sakai, G. Lambert et al., “Conditional disruption of the peroxisome proliferator-activated receptor ? gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux,” Molecular and Cellular Biology, vol. 22, no. 8, pp. 2607–2619, 2002. View at Publisher · View at Google Scholar
  45. J. R. Jones, C. Barrick, K.-A. Kim et al., “Deletion of PPAR? in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 17, pp. 6207–6212, 2005. View at Publisher · View at Google Scholar
  46. U. B. Pajvani, M. E. Trujillo, T. P. Combs et al., “Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy,” Nature Medicine, vol. 11, no. 7, pp. 797–803, 2005. View at Publisher · View at Google Scholar
  47. A. W. Norris, L. Chen, S. J. Fisher et al., “Muscle-specific PPAR?-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones,” Journal of Clinical Investigation, vol. 112, no. 4, pp. 608–618, 2003. View at Publisher · View at Google Scholar
  48. A. L. Hevener, W. He, Y. Barak et al., “Muscle-specific Pparg deletion causes insulin resistance,” Nature Medicine, vol. 9, no. 12, pp. 1491–1497, 2003. View at Publisher · View at Google Scholar
  49. K. Matsusue, M. Haluzik, G. Lambert et al., “Liver-specific disruption of PPAR? in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes,” Journal of Clinical Investigation, vol. 111, no. 5, pp. 737–747, 2003. View at Publisher · View at Google Scholar
  50. O. Gavrilova, M. Haluzik, K. Matsusue et al., “Liver peroxisome proliferator-activated receptor ? contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass,” Journal of Biological Chemistry, vol. 278, no. 36, pp. 34268–34276, 2003. View at Publisher · View at Google Scholar
  51. E. D. Rosen, R. N. Kulkarni, P. Sarraf et al., “Targeted elimination of peroxisome proliferator-activated receptor ? in ß cells leads to abnormalities in islet mass without compromising glucose homeostasis,” Molecular and Cellular Biology, vol. 23, no. 20, pp. 7222–7229, 2003. View at Publisher · View at Google Scholar
  52. P. Tontonoz, L. Nagy, J. G. A. Alvarez, V. A. Thomazy, and R. M. Evans, “PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL,” Cell, vol. 93, no. 2, pp. 241–252, 1998. View at Publisher · View at Google Scholar
  53. M. Ricote, A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass, “The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation,” Nature, vol. 391, no. 6662, pp. 79–82, 1998. View at Publisher · View at Google Scholar
  54. A. C. Li, K. K. Brown, M. J. Silvestre, T. M. Willson, W. Palinski, and C. K. Glass, “Peroxisome proliferator-activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice,” Journal of Clinical Investigation, vol. 106, no. 4, pp. 523–531, 2000. View at Google Scholar
  55. A. Chawla, Y. Barak, L. Nagy, D. Liao, P. Tontonoz, and R. M. Evans, “PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation,” Nature Medicine, vol. 7, no. 1, pp. 48–52, 2001. View at Publisher · View at Google Scholar
  56. A. Chawla, W. A. Boisvert, C.-H. Lee et al., “A PPAR?-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis,” Molecular Cell, vol. 7, no. 1, pp. 161–171, 2001. View at Publisher · View at Google Scholar
  57. V. R. Babaev, P. G. Yancey, S. V. Ryzhov et al., “Conditional knockout of macrophage PPAR? increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 8, pp. 1647–1653, 2005. View at Publisher · View at Google Scholar
  58. G. Pascual, M. Ricote, A. Hevener et al., “Anti-inflammatory and antidiabetic roles of PPAR? in macrophages,” in Proceedings of Keystone Symposia: Adipogenesis, Obesity and Inflammation, Vancouver, British Columbia, Canada, January 2006, 004a.
  59. N. K. Hollenberg, “Considerations for management of fluid dynamic issues associated with thiazolidinediones,” American Journal of Medicine, vol. 115, no. 8, supplement 1, pp. 111–115, 2003. View at Publisher · View at Google Scholar
  60. H. Zhang, A. Zhang, D. E. Kohan, R. D. Nelson, F. J. Gonzalez, and T. Yang, “Collecting duct-specific deletion of peroxisome proliferator-activated receptor γ blocks thiazolidinedione-induced fluid retention,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 26, pp. 9406–9411, 2005. View at Publisher · View at Google Scholar
  61. Y. Guan, C. Hao, D. R. Cha et al., “Thiazolidinediones expand body fluid volume through PPAR? stimulation of ENaC-mediated renal salt absorption,” Nature Medicine, vol. 11, no. 8, pp. 861–866, 2005. View at Publisher · View at Google Scholar
  62. C. J. Nicol, M. Adachi, T. E. Akiyama, and F. J. Gonzalez, “PPARγ in endothelial cells influences high fat diet-induced hypertension,” American Journal of Hypertension, vol. 18, no. 4, pp. 549–556, 2005. View at Publisher · View at Google Scholar
  63. S. Z. Duan, C. Y. Ivashchenko, M. W. Russell, D. S. Milstone, and R. M. Mortensen, “Cardiomyocyte-specffic knockout and agonist of peroxisome proliferator-activated receptor-γ both induce cardiac hypertrophy in mice,” Circulation Research, vol. 97, no. 4, pp. 372–379, 2005. View at Publisher · View at Google Scholar
  64. S. A. Kliewer, B. M. Forman, B. Blumberg et al., “Differential expression and activation of a family of murine peroxisome proliferator-activated receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 15, pp. 7355–7359, 1994. View at Publisher · View at Google Scholar
  65. P. Tontonoz, E. Hu, R. A. Graves, A. I. Budavari, and B. M. Spiegelman, “mPPARγ2: tissue-specific regulator of an adipocyte enhancer,” Genes and Development, vol. 8, no. 10, pp. 1224–1234, 1994. View at Publisher · View at Google Scholar
  66. J. Zhang, M. Fu, T. Cui et al., “Selective disruption of PPAR?2 impairs the development of adipose tissue and insulin sensitivity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 29, pp. 10703–10708, 2004. View at Publisher · View at Google Scholar
  67. G. Medina-Gomez, S. Virtue, C. Lelliott et al., “The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-?2 isoform,” Diabetes, vol. 54, no. 6, pp. 1706–1716, 2005. View at Publisher · View at Google Scholar
  68. H. Koutnikova, T.-A. Cock, M. Watanabe et al., “Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR? hypomorphic mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 24, pp. 14457–14462, 2003. View at Publisher · View at Google Scholar
  69. I. Barroso, M. Gurnell, V. E. F. Crowley et al., “Dominant negative mutations in human PPAR? associated with severe insulin resistance, diabetes mellitus and hypertension,” Nature, vol. 402, no. 6764, pp. 880–883, 1999. View at Publisher · View at Google Scholar
  70. A. K. Agarwal and A. Garg, “A novel heterozygous mutation in peroxisome proliferator-activated receptor-γ gene in a patient with familial partial lipodystrophy,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 1, pp. 408–411, 2002. View at Publisher · View at Google Scholar
  71. R. A. Hegele, H. Cao, C. Frankowski, S. T. Mathews, and T. Leff, “PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy,” Diabetes, vol. 51, no. 12, pp. 3586–3590, 2002. View at Publisher · View at Google Scholar
  72. D. B. Savage, M. Agostini, I. Barroso et al., “Digenic inheritance of severe insulin resistance in a human pedigree,” Nature Genetics, vol. 31, no. 4, pp. 379–384, 2002. View at Publisher · View at Google Scholar
  73. M. Gurnell, D. B. Savage, V. K. K. Chatterjee, and S. O'Rahilly, “The metabolic syndrome: peroxisome proliferator-activated receptor γ and its therapeutic modulation,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 6, pp. 2412–2421, 2003. View at Publisher · View at Google Scholar
  74. Y.-S. Tsai, H.-J. Kim, N. Takahashi et al., “Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPAR?,” Journal of Clinical Investigation, vol. 114, no. 2, pp. 240–249, 2004. View at Publisher · View at Google Scholar
  75. B. D. Freedman, E.-J. Lee, Y. Park, and J. L. Jameson, “A dominant negative peroxisome proliferator-activated receptor-γ knock-in mouse exhibits features of the metabolic syndrome,” Journal of Biological Chemistry, vol. 280, no. 17, pp. 17118–17125, 2005. View at Publisher · View at Google Scholar
  76. E. Hu, J. B. Kim, P. Sarraf, and B. M. Spiegelman, “Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ,” Science, vol. 274, no. 5295, pp. 2100–2103, 1996. View at Publisher · View at Google Scholar
  77. M. Ristow, D. Müller-Wieland, A. Pfeiffer, W. Krone, and C. R. Kahn, “Obesity associated with a mutation in a genetic regulator of adipocyte differentiation,” New England Journal of Medicine, vol. 339, no. 14, pp. 953–959, 1998. View at Publisher · View at Google Scholar
  78. S. S. Deeb, L. Fajas, M. Nemoto et al., “A Pro12Ala substitution in PPAR?2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity,” Nature Genetics, vol. 20, no. 3, pp. 284–287, 1998. View at Publisher · View at Google Scholar
  79. D. Altshuler, J. N. Hirschhorn, M. Klannemark et al., “The common PPAR? Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes,” Nature Genetics, vol. 26, no. 1, pp. 76–80, 2000. View at Publisher · View at Google Scholar
  80. S. M. Rangwala, B. Rhoades, J. S. Shapiro et al., “Genetic modulation of PPAR? phosphorylation regulates insulin sensitivity,” Developmental Cell, vol. 5, no. 4, pp. 657–663, 2003. View at Publisher · View at Google Scholar
  81. Y. Barak, D. Liao, W. He et al., “Effects of peroxisome proliferator-activated receptor d on placentation, adiposity, and colorectal cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 1, pp. 303–308, 2002. View at Publisher · View at Google Scholar
  82. A. Chawla, C.-H. Lee, Y. Barak et al., “PPARd is a very low-density lipoprotein sensor in macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 3, pp. 1268–1273, 2003. View at Publisher · View at Google Scholar
  83. K. Nadra, S. I. Anghel, E. Joye et al., “Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor ß/d,” Molecular and Cellular Biology, vol. 26, no. 8, pp. 3266–3281, 2006. View at Publisher · View at Google Scholar
  84. J. M. Peters, S. S.-T. Lee, W. Li et al., “Growths, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor ß(d),” Molecular and Cellular Biology, vol. 20, no. 14, pp. 5119–5128, 2000. View at Publisher · View at Google Scholar
  85. M. Schuler, F. Ali, C. Chambon et al., “PGC1a expression is controlled in skeletal muscles by PPARß, whose ablation results in fiber-type switching, obesity, and type 2 diabetes,” Cell Metabolism, vol. 4, no. 5, pp. 407–414, 2006. View at Publisher · View at Google Scholar
  86. T. E. Akiyama, G. Lambert, C. J. Nicol et al., “Peroxisome proliferator-activated receptor ß/d regulates very low density lipoprotein production and catabolism in mice on a Western diet,” Journal of Biological Chemistry, vol. 279, no. 20, pp. 20874–20881, 2004. View at Publisher · View at Google Scholar
  87. Y.-X. Wang, C.-H. Lee, S. Tiep et al., “Peroxisome-proliferator-activated receptor d activates fat metabolism to prevent obesity,” Cell, vol. 113, no. 2, pp. 159–170, 2003. View at Publisher · View at Google Scholar
  88. Y.-X. Wang, C.-L. Zhang, R. T. Yu et al., “Regulation of muscle fiber type and running endurance by PPARd,” PLoS Biology, vol. 2, no. 10, p. e294, 2004. View at Publisher · View at Google Scholar
  89. S. Luquet, J. Lopez-Soriano, D. Holst et al., “Peroxisome proliferator-activated receptor d controls muscle development and oxidative capability,” FASEB Journal, vol. 17, no. 15, pp. 2299–2301, 2003. View at Publisher · View at Google Scholar
  90. C.-H. Lee, P. Olson, A. Hevener et al., “PPARd regulates glucose metabolism and insulin sensitivity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 9, pp. 3444–3449, 2006. View at Publisher · View at Google Scholar
  91. L. Cheng, G. Ding, Q. Qin et al., “Cardiomyocyte-restricted peroxisome proliferator-activated receptor-d deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy,” Nature Medicine, vol. 10, no. 11, pp. 1245–1250, 2004. View at Publisher · View at Google Scholar
  92. C.-H. Lee, A. Chawla, N. Urbiztondo et al., “Transcriptional repression of atherogenic inflammation: modulation by PPARd,” Science, vol. 302, no. 5644, pp. 453–457, 2003. View at Publisher · View at Google Scholar